Illinois is facing an intense battle over a federal program requiring drug manufacturers to sell deeply discounted ...

In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...

The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...

Kansas legislators, Republican and Democrat, are frustrated bills to help control prescription drug prices are blocked by GOP ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...

On July 31, 2025, notice was published in the Federal Register by the Health Resources and Services Administration (“HRSA”) of a “340B Rebate Model Pilot Program” (“340B Pilot Program”). The 340B ...

Reforming the federal 340B Drug Pricing Program is a fast and efficient way to reduce drug costs and protect patients. These days, some 340B hospitals are taking advantage of low-income and uninsured ...

The change is expected to save the state’s Medicaid program approximately $63 million annually, but safety-net care providers ...

The 340B Drug Pricing Program allows certain medical facilities to buy drugs at a discount to support care for low-income patients. Rhode Island's new law, Chapter 288, prevents drug makers from ...